NCT01426191View on ClinicalTrials.gov

Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

CompletedOBSERVATIONAL

Enrollment

2,032

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

December 31, 2016

Conditions

Respiratory Tract InfectionsUrinary Tract Infections

Interventions

DRUG

xinzhijun

"durg:Cefotaxime sodium and sulbactam sodium for injection(2:1)~1.5-3.0g,iv,bid or tid for 5-12 days;~Serious infections:1.0-1.5g,iv,tid or qid for 5-12 days"

All Listed Sponsors

lead

Xiangbei Welman Pharmaceutical Co., Ltd

INDUSTRY

NCT01426191 - Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection | Biotech Hunter | Biotech Hunter